Muenchener Rueck

Good 2020 results in COVID times, strong January renewals

25/02/21 -"• Net profit attributable to shareholders decreased by 56% to €1.21bn for 2020 but was in line with the revised company guidance • COVID-19-related losses were €3.5bn in FY2020 • The dividend ..."

PDF page sample
Pages
56
Language
English
Published on
25/02/21
Download
You may also be interested by these reports :
14/11/25
Allianz reported strong Q3 results, particularly in Property & Casualty. Operating profit for 9M25 increased by more than 10%, prompting management ...
14/11/25
Generali’s 3Q results were strong across all divisions, with solid volume growth and favourable margin trends in both Life and P&C – once adjusted ...
14/11/25
Generali reported a strong set of 3Q25 results, with positive volume and margin development in Life and a solid combined ratio in Property & ...
13/11/25
Talanx reported strong 3Q25 results, above consensus expectations, and raised its net profit guidance for both FY25 and FY26. We believe the new ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO